YS company's HBV patent valuation through reopening auctionYS company's HBV patent valuation through reopening auction
On September 15, 2023, YS Biopharma increased by 9% and reached a point of control (POC) at a value of one dollar per share. The market value of this company was 86.580 million dollars before the reopening due to the publication of the news